MDM2 and neoplasm: HSP90 inhibitors, e.g. 17-AAG, degrade mutp53 by favoring its MDM2-mediated ubiquitination [40], and we have shown that DCA cooperates with 17-AAG to kill mutp53 tumor cells [7].